Literature DB >> 33194020

Development and validation of a nomogram for predicting nonalcoholic fatty liver disease in the non-obese Chinese population.

Jiao Wang1, Yunliang Tang2, Kaili Peng3, Honghong Liu1, Jixiong Xu1.   

Abstract

The purpose of this study was to construct and validate a model for predicting nonalcoholic fatty liver disease (NAFLD) in the non-obese Chinese population. A total of 13240 NAFLD-free individuals at baseline from a 4-y longitudinal study were allocated to a training cohort (n=8872) and a validation cohort (n=4368). The overall incidence of NAFLD was 13%. Nine significant predictors including age, gender, body mass index, fasting blood glucose, total cholesterol, triglycerides, high-density lipoprotein cholesterol, uric acid and alanine aminotransferase were identified and constructed for the nomogram using cox proportional hazards regression analyses. The concordance index was 0.804 and 0.802 in the training and validation cohorts, respectively. In the training cohort, the area under the ROC curve (AUC) for 1-y, 2-y, 3-y and 4-y risk was 0.835, 0.825, 0.816 and 0.782, respectively. Likewise, in the validation cohort, the AUC for 1-y, 2-y, 3-y and 4-y risk was 0.817, 0.820, 0.814 and 0.813. The calibration curves for NAFLD risk showed excellent accuracy in the predictive modeling of the nomogram, internally and externally. The nomogram categorized individuals into high- and low-risk groups, and the DCA displayed the clinical usefulness of the nomogram for predicting NAFLD incidence. Our nomogram can predict a personalized risk of NAFLD in the non-obese Chinese population. This nomogram can serve as a simple and affordable tool for stratifying individuals at a high risk of NAFLD, and thus serve to expedite treatment of NAFLD. AJTR
Copyright © 2020.

Entities:  

Keywords:  Nonalcoholic fatty liver disease; nomogram; predictive modeling; risk factor

Year:  2020        PMID: 33194020      PMCID: PMC7653603     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  22 in total

Review 1.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

Review 2.  Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

Authors:  Leon A Adams; Quentin M Anstee; Herbert Tilg; Giovanni Targher
Journal:  Gut       Date:  2017-03-17       Impact factor: 23.059

3.  Nomogram: An analogue tool to deliver digital knowledge.

Authors:  Seo Young Park
Journal:  J Thorac Cardiovasc Surg       Date:  2018-01-06       Impact factor: 5.209

Review 4.  Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.

Authors:  Zhong-Hua Lin; Yong-Ning Xin; Quan-Jiang Dong; Qing Wang; Xiang-Jun Jiang; Shu-Hui Zhan; Ying Sun; Shi-Ying Xuan
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

5.  Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population.

Authors:  T C-F Yip; A J Ma; V W-S Wong; Y-K Tse; H L-Y Chan; P-C Yuen; G L-H Wong
Journal:  Aliment Pharmacol Ther       Date:  2017-06-06       Impact factor: 8.171

6.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

Review 7.  Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers.

Authors:  Eduardo Vilar-Gomez; Naga Chalasani
Journal:  J Hepatol       Date:  2017-12-02       Impact factor: 25.083

8.  Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

Authors:  S A Harrison; D Oliver; H L Arnold; S Gogia; B A Neuschwander-Tetri
Journal:  Gut       Date:  2008-04-04       Impact factor: 23.059

9.  Application of Machine Learning Techniques for Clinical Predictive Modeling: A Cross-Sectional Study on Nonalcoholic Fatty Liver Disease in China.

Authors:  Han Ma; Cheng-Fu Xu; Zhe Shen; Chao-Hui Yu; You-Ming Li
Journal:  Biomed Res Int       Date:  2018-10-03       Impact factor: 3.411

10.  NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD.

Authors:  Münevver Demir; Sonja Lang; Martin Schlattjan; Uta Drebber; Inga Wedemeyer; Dirk Nierhoff; Ingrid Kaul; Jan Sowa; Ali Canbay; Ulrich Töx; Hans-Michael Steffen
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more
  1 in total

1.  Risk factors and prediction model for nonalcoholic fatty liver disease in northwest China.

Authors:  Danting Li; Meiyu Zhang; Shengli Wu; Huiwen Tan; Nong Li
Journal:  Sci Rep       Date:  2022-08-16       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.